An Optimal Control Approach for the Treatment of Solid Tumors with Angiogenesis Inhibitors
Cancer is a disease of unregulated cell growth that is estimated to kill over 600,000 people in the United States in 2017 according to the National Institute of Health. While there are several therapies to treat cancer, tumor resistance to these therapies is a concern. Drug therapies have been devel...
Main Authors: | Adam E. Glick, Antonio Mastroberardino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Mathematics |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-7390/5/4/49 |
Similar Items
-
Optimal control analysis of combined anti-angiogenic and tumor immunotherapy
by: Anuraag Bukkuri
Published: (2019-11-01) -
Current Concepts in Multi-Modality Imaging of Solid Tumor Angiogenesis
by: Moataz A. Soliman, et al.
Published: (2020-11-01) -
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
by: Patrizia Leone, et al.
Published: (2019-11-01) -
Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
by: Aini Hyytiäinen, et al.
Published: (2021-06-01) -
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
by: Raluca Ioana Teleanu, et al.
Published: (2019-12-01)